Xenetic Biosciences Announces $12.5 Million Private Stock Sale
editor In full transparency, the following is a press release *** FRAMINGHAM – Xenetic Biosciences, a Framingham-based biopharmaceutical company focused on advancing XCART™, a personalized CAR T platform technology engineered to…